Mycobacterium colombiense in a Mexican Patient with HIV Identified by DNA Sequencing Mycobacterium Colombiense

Main Article Content

Leora Velasquez.Perez
Jaime Vazquez-Moreno
Rosa Guadalupe Salazar-Nava

Abstract

Mycobacterium colombiense is a rare nontuberculous mycobacterium (NTM) associated with respiratory disease, belonging to the Mycobacterium avium complex (MAC). We present the case of a 39-year-old male from Mexico City, diagnosed with stage 4 Human Immunodeficiency Virus (HIV), in whom Mycobacterium colombiense was isolated from bone marrow using DNA sequencing, without evidence of pulmonary disease. This is the first case of isolation in Mexico. Because NTM cultures take 2 – 3 weeks to grow, the diagnosis is generally delayed, highlighting the need to implement molecular testing for rapid diagnosis and timely treatment initiation .

Article Details

Velasquez.Perez, L., Vazquez-Moreno, J., & Salazar-Nava, R. G. (2025). Mycobacterium colombiense in a Mexican Patient with HIV Identified by DNA Sequencing: Mycobacterium Colombiense. Archives of Case Reports, 9(3), 132–134. https://doi.org/10.29328/journal.acr.1001133
Case Presentations

Copyright (c) 2025 Vázquez-Moreno J.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Leora Velasquez.Perez, a:1:{s:5:"en_US";s:50:"Instituto Nacional de Neurología y Neurocirugía ";}

Epidemiology department head. National Institute of Neurology and Neurosurgery

[1] Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV. National Institutes of Health, HIV Medicine Association, and Infectious Diseases Society of America. Available at: https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection

[2] Yu X, et al. Mycobacterium colombiense and Mycobacterium avium Complex Causing Severe Pneumonia in a Patient with HIV Identified by a Novel Molecular-Based Method. Infection and Drug Resistance. 2021; Vol 14, 11–6 [citado 03 Ene 2025]. DOI:10.2147/IDR.S282190. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7797356/

[3] Tang M, Zeng W, Qiu Y, Fang G, Pan M, Li W, et al. Clinical features of rare disseminated Mycobacterium colombiense infection in nine patients who are HIV-negative in Guangxi, China. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2023; Vol 1 Num 128; 321–4 [cited 13 Ene 2025]; DOI:10.1016/j.ijid.2023.01.002. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36642210/

[4] Rodrigues A, et al. A fatal case of pulmonary infection by Mycobacterium colombiense in Para State, Amazon Region, Brazil. Diagn Microbiol Infect Dis. 2016. Vol. 85 Num. 3, 344-6. [cited 13 Ene 2025]. DOI: 10.1016/j.diagmicrobio.2016.02.011. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27133309/

[5] Pennington K, et al. Aproximación al diagnóstico y tratamiento de la enfermedad micobacteriana no tuberculosa. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2021. Vol. 24 [citado 19 feb 2025]; DOI: https://doi.org/10.1016/j.jctube.2021.100244. Disponible en: https://www.sciencedirect.com/science/article/pii/S2405579421000334?via%3Dihub